Skip to content

Ayurvedic Management of Shushkaakshipaka (Dry Eye Disease ) by using Shunthyadi Aschyotana (Eye Drop) with Mahatriphaladi Ghrita Pana and Mridweekaadi Aschyotana (Eye Drop) with Mahatriphaladi Ghrita Pana.

Efficacy of Shunthyadi Aschyotana (Eye Drop) with Mahatriphaladi Ghrita Pana and Mridweekaadi Aschyotana (Eye Drop) with Mahatriphaladi Ghrita Pana in the management of Shushkaakshipaka (Dry Eye Disease) - An Open Labelled Randomized Comparative Clinical Trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051076
Enrollment
30
Registered
2023-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients in the age group 18-50 years irrespective of sex, caste, religion. 2. Patients having minimum three symptoms of Dry Eye Disease. 3. Patients having minimum 2 findings of below tests: i. Schirmer strip wetting of between 1-15 mm in 5 minutes: Schirmer- I test. ii. The appearance of dry spot between 1-15 seconds: Fluorescein Tear Film Break Up Test (F-TBUT). iii. Mild to Severe Staining (Superficial to dense staining): Fluorescein Staining. iv. Mild to Severe Staining (Dot count 1-30): Rose Bengal Staining (Oxford scheme of scoring).

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and more than 50 years. 2. Dry Eye due to any local cause e.g., Chemical Burn, Xerosis etc. 3. Dry Eye due to systemic disease like Sjogrenâ??s Syndrome. 4. Patients on Steroids, Oral Contraceptive Pills, Estrogen Replacement Therapy or any other medication such as Antispasmodic drugs like Atropine that may adversely affect the outcome of the study. 5. Persistent contact lens users. 6. Patients having chronic debilitating diseases like HIV, Tuberculosis, Malignancy, uncontrolled Diabetes Mellitus and Hypertensive.

Design outcomes

Primary

MeasureTime frame
Relief in Subjective and Objective criteria of Shushkaakshipaka ( Dry Eye Disease).Timepoint: 1-2 month

Secondary

MeasureTime frame
Long-lasting effect of Ayurvedic interventionTimepoint: 1-2 month

Countries

India

Contacts

Public ContactDr Deepak K Pawar

Institute of Teaching and Research in Ayurveda

drpawar29@itra.edu.in7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026